These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

184 related items for PubMed ID: 6099904

  • 21. Herpes simplex virus type 2 and carcinoma of cervix uteri.
    Vardthananusara C, Wasi C, Usavajindawatn C, Thongchareon P.
    J Med Assoc Thai; 1978 Jan; 61(1):14-9. PubMed ID: 204721
    [No Abstract] [Full Text] [Related]

  • 22. Clinicoepidemiologic aspects and association of genital herpes and cervical neoplasia.
    Nahmias AJ, Kawana T, Del Buono I.
    Adv Pathobiol; 1976 Jan; (5):42-53. PubMed ID: 220857
    [No Abstract] [Full Text] [Related]

  • 23. Serological studies against herpes simplex virus types I & II in cervical carcinoma patients.
    Rajeswari N, Thyagarajan SP, Kanaklata, Rajendran P, Subramanian S, Vaideeswaran, Shanta V.
    Indian J Pathol Microbiol; 1987 Apr; 30(2):157-62. PubMed ID: 2856216
    [No Abstract] [Full Text] [Related]

  • 24. Herpes simplex type 2 and cervical cancer: immunological and in situ hybridization studies.
    Simard R, Kessous A, Mansour M, Camonis J, Rawls WE.
    Prog Clin Biol Res; 1983 Apr; 132D():461-9. PubMed ID: 6314363
    [No Abstract] [Full Text] [Related]

  • 25. Chlamydia trachomatis and cervical neoplasia.
    Schachter J, Hill EC, King EB, Heilbron DC, Ray RM, Margolis AJ, Greenwood SA.
    JAMA; 1982 Nov 05; 248(17):2134-8. PubMed ID: 6288978
    [Abstract] [Full Text] [Related]

  • 26. [Relationship between Herpes simplex virus type 2 and carcinoma of the uterine cervix].
    Janda J.
    Cesk Gynekol; 1973 Jul 05; 38(6):454-60. PubMed ID: 4354419
    [No Abstract] [Full Text] [Related]

  • 27. Correlation between immune complexes and herpes simplex virus (HSV)-tumor associated antigen (TAA) in human cancer sera.
    Cocchiara R, Tarro G, Flaminio G, Geraci D.
    Cell Mol Biol; 1983 Jul 05; 29(5):397-403. PubMed ID: 6313196
    [No Abstract] [Full Text] [Related]

  • 28. Genital cancer and viruses.
    Rapp F, Jenkins FJ.
    Gynecol Oncol; 1981 Oct 05; 12(2 Pt 2):S25-41. PubMed ID: 6273264
    [No Abstract] [Full Text] [Related]

  • 29. Seroepidemiologic studies of herpesvirus type 2 and carcinoma of the cervix. II. Uganda.
    Adam E, Sharma SD, Zeigler O, Iwamoto K, Melnick JL, Levy AH, Rawls WE.
    J Natl Cancer Inst; 1972 Jan 05; 48(1):65-72. PubMed ID: 4347030
    [No Abstract] [Full Text] [Related]

  • 30. Relation of type 2 Herpesvirus antibodies to cervical neoplasia. Barbados, West Indies, 1971.
    Ory H, Conger B, Richart R, Barron B.
    Obstet Gynecol; 1974 Jun 05; 43(6):901-4. PubMed ID: 4364212
    [No Abstract] [Full Text] [Related]

  • 31. Herpes simplex virus type-specific antibodies detected by indirect and competition ELISA. Comparison of sera from patients with carcinoma of the uterine cervix, age matched controls and patients with recurrent genital herpes.
    Najem SN, Vestergaard BF, Potter CW.
    Acta Pathol Microbiol Immunol Scand B; 1983 Jun 05; 91(3):205-7. PubMed ID: 6308950
    [Abstract] [Full Text] [Related]

  • 32. AG-4 complement-fixing antibodies in cervical cancer and herpes-infected patients using local herpes simplex virus type 2.
    Arsenakis M, Georgiou GM, Welsh JK, Cauchi MN, May JT.
    Int J Cancer; 1980 Jan 15; 25(1):67-71. PubMed ID: 6249764
    [Abstract] [Full Text] [Related]

  • 33. Herpes simplex virus and human papilloma virus in the development of cervical carcinoma.
    Kaufman RH, Adam E.
    Clin Obstet Gynecol; 1986 Sep 15; 29(3):678-92. PubMed ID: 3019599
    [No Abstract] [Full Text] [Related]

  • 34. Antibodies to the herpes simplex virus type-2-induced tumor-associated antigen AG-4 as markers of recurrence in cervical cancer.
    te Velde ER, Aurelian L.
    Tumour Biol; 1987 Sep 15; 8(1):26-33. PubMed ID: 3037680
    [Abstract] [Full Text] [Related]

  • 35. The role of herpes virus in cancer of the cervix.
    Wilbanks GD.
    Obstet Gynecol Annu; 1976 Sep 15; 5():315-29. PubMed ID: 185549
    [No Abstract] [Full Text] [Related]

  • 36. Prevention of type 2 herpes simplex virus induced cervical carcinoma in mice by prior immunization with a vaccine prepared from type 1 herpes simplex virus.
    Chen MH, Dong CY, Liu ZH, Skinner GR, Hartley CE.
    Vaccine; 1983 Dec 15; 1(1):13-6. PubMed ID: 6099637
    [Abstract] [Full Text] [Related]

  • 37. [Serum HSV-2 antibody in males from high and low incidence areas of cervical cancer].
    Chen WK, Cheng L, Guo SF, Xiang JM.
    Zhonghua Zhong Liu Za Zhi; 1986 May 15; 8(3):199-200. PubMed ID: 3017663
    [Abstract] [Full Text] [Related]

  • 38. Association of herpes simplex type 2 virus with cervical cancer of the uterus.
    Kao CL, Chen YH, Tang MC, Wen HK, Hsia S.
    Taiwan Yi Xue Hui Za Zhi; 1974 Feb 15; 73(2):122-7. PubMed ID: 4368434
    [No Abstract] [Full Text] [Related]

  • 39. A nonhuman primate model for the study of the cervical oncogenic potential of herpes simplex virus type 2.
    London WT, Nahmias AJ, Naib ZM, Fuccillo DA, Ellenberg JH, Sever JL.
    Cancer Res; 1974 May 15; 34(5):1118-21. PubMed ID: 4366986
    [No Abstract] [Full Text] [Related]

  • 40. Antibodies to herpes simplex virus (types 1 and 2) in Jamaican patients with cervical dysplasia and neoplasia.
    Prabhakar P, Rao BN, Hosang R, Narla VR, Persaud V.
    West Indian Med J; 1984 Jun 15; 33(2):63-7. PubMed ID: 6091343
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.